Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-12

Clinical Trial Update: Efficacy and Safety of 0.25% Timolol Gel in Healing Surgical Open Wounds [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating 0.25% Timolol Gel for healing surgical open wounds has completed to assess efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • timolol gel 0.25% (timolol)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Wound of Skin, Wound Heal | Phase 2, Phase 3 | Status: COMPLETED